CARDIOGENIC SHOCK POST MYOCARDIAL INFARCTION
Clinical trials for CARDIOGENIC SHOCK POST MYOCARDIAL INFARCTION explained in plain language.
Never miss a new study
Get alerted when new CARDIOGENIC SHOCK POST MYOCARDIAL INFARCTION trials appear
Sign up with your email to follow new studies for CARDIOGENIC SHOCK POST MYOCARDIAL INFARCTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Experimental cell treatment targets heart attack shock
Disease control Not yet recruitingThis early-phase trial tests a new treatment made from specially engineered immune cells (CAR-DC) for people who have had a severe heart attack and are in shock. The treatment targets a protein called FAP to calm harmful inflammation. The study will enroll 18 adults and primarily…
Matched conditions: CARDIOGENIC SHOCK POST MYOCARDIAL INFARCTION
Phase: PHASE1 • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated May 17, 2026 06:47 UTC
-
Hong kong launches registry to improve survival in heart attack shock
Knowledge-focused Not yet recruitingThis study is a registry that will collect information from about 320 people in Hong Kong who have had a severe heart attack complicated by cardiogenic shock, a condition where the heart cannot pump enough blood. The goal is to track outcomes for patients who receive a mechanical…
Matched conditions: CARDIOGENIC SHOCK POST MYOCARDIAL INFARCTION
Sponsor: Prince of Wales Hospital, Shatin, Hong Kong • Aim: Knowledge-focused
Last updated Apr 26, 2026 19:36 UTC